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ABSTRACT
Objectives: The objective of this study is to assess the
impact of nocturia on sleep in patients with lower
urinary tract symptoms (LUTS)/benign prostatic
enlargement (BPE) (nocturia$2).
Design: Cross-sectional survey.
Setting: 798 urologists and general practitioners
randomly selected from the overall population of
urologists and general practitioners of every French
region.
Participants: A total of 2179 LUTS/BPE men (aged
67.567.5 years old) were recruited.
Primary and secondary outcome
measures: Validated patients’ self-administered
questionnaires were used to assess the severity of
LUTS/BPE (the International Prostate Symptom
Score), sleep characteristics (sleep log) and sleep
disorders (the International Classiﬁcation of Sleep
Disorders (ICSD-2) and the DSM-IV). Sleepiness was
assessed with the Epworth Sleepiness Scale (ESS).
The volume of 24 h diuresis (<or >1500 ml) was
measured.
Results: Participants had on average 2.960.9 nocturia
episodes (three or more episodes in 67%) and the
International Prostate Symptom Score of 15.865.7;
60.9% complained of insomnia according to the
ICSD-2, 7.9% of restless leg syndrome and 6.4% of
obstructive sleep apnoea. 32.3% had excessive
sleepiness (ESS >10) and 3.1% severe excessive
sleepiness (ESS >16). Insomnia was mainly nocturnal
awakenings with an average wake after sleep onset of
89647 min. The number of episodes of nocturia per
night correlated signiﬁcantly with wake after sleep
onset and ESS but not with total sleep time and sleep
latency.
Conclusion: Nocturia is signiﬁcantly associated with
sleep maintenance insomnia and sleepiness in men
with BPE.
INTRODUCTION
Nocturia caused by benign prostatic hyper-
plasia is a major complaint of men over
50 years who cite sleep disruption (needing
to wake up at night to void) as the main
reason for visiting their doctor rather than
because of any daytime problems with
urinating.
1e6 After excluding chronic and
severe diseases such as diabetes or prostatic
cancer, nocturia is mostly classiﬁed within the
‘moderate to severe lower urinary tract
symptoms’ (LUTS) category, which includes
the vast majority of patients. Twenty-nine per
cent of men over 50 years old are affected by
LUTS.
12In France, the rate was recently
found to be even higher, affecting 57.5% of
men over 55 years old and is mainly attrib-
uted to a benign prostatic hyperplasia or
benign prostatic enlargement (BPE).
3 While
voiding once or twice per night and going
back to sleep is often considered within
normal limits by the vast majority of men,
several voids per night are likely to be
disruptive to sleep.
4e9 Recently, two studies
done in Europe (Denmark and France) have
shown that about one-third of men aged
40e80 years reported two or more episodes
of nocturia leading to sleep interruption.
91 0
The prevalence of nocturia increased with
age, with the perceived inconvenience and
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ARTICLE SUMMARY
Article focus
- Complaint of nocturia and its links with excessive
sleepiness.
- Assessment of the impact of nocturia on sleep.
Key messages
- By being disruptive to sleep, the nocturia
episodes affected sleep efﬁciency and quality.
- The number of nocturia episodes was associated
with an increased sleepiness in men with benign
prostatic hyperplasia.
Strengths and limitations of this study
- This is a cross-sectional study. It would have
been more convincing to compare our subjects
to a similar group of older people with no benign
prostatic hyperplasia. However, our study
focused on the frequency of insomnia and
on the correlates between benign prostatic
hyperplasia and insomnia.
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Open Access Researchquality-of-life (QoL) impairment being most important
as the severity of nocturia increased. The vast majority of
these patients talked to their general practitioner (GP)
but few consulted a specialist even in the most severe
cases. Among French subjects presenting two or more
nocturia per night, fewer than one-third had consulted
a urologist with 20% receiving a urologic treatment
within the past 6 months.
91 0
Insomnia is also a major complaint in general prac-
tice.
11 Epidemiological studies performed in general
population samples in Western Europe showed a high
prevalence of insomnia symptoms, affecting 10%e20%
of adults.
11e15 Insomnia is deﬁned, according to DSM-IV
and International Classiﬁcation of Sleep Disorders
(ICSD-2) consensual deﬁnitions, as a complaint of
“difﬁculty initiating sleep, nocturnal awakenings, early
awakenings and/or non-restorative sleep, occurring at
least three nights per week, for more than 1 month and
accompanied by daytime consequences”.
16 17 Nocturnal
awakenings with difﬁculties going back to sleep is one of
the major issues, with the worst consequences on
daytime functioning the next day. Its prevalence
increases signiﬁcantly with age.
13e15 18 19 However,
surprisingly, almost half of the subjects with insomnia
did not discuss it at all with a physician. Of the few
individuals who did, fewer than 20% were correctly
diagnosed (according to consensual deﬁnitions of sleep
disorders) and treated.
14 15 18 19
LUTS, and more particularly nocturia and insomnia,
remain under-reported and under-treated symptoms,
leading to a considerable burden and a major public
health issue due to their consequences on QoL. Both are
highly prevalent in the general population and their
respective prevalence increases with age. Both are
recurrent causes of visits to GPs. However, the link
between nocturia and sleep disorders in ageing men has
not been strictly evaluated.
The goal of this cross-sectional multicenter survey
(which we called ‘MORPHEE’) was therefore to assess in
a subgroup of LUTS/BPE patients the links between
nocturia and sleep characteristics and disorders using
well-deﬁned and internationally admitted instruments.
METHODS
Centres and patients
The study was organised by the French Urologic Asso-
ciation (AFU), a non-proﬁt professional association
whose members are urologic surgeons practicing in
France in the public and private systems and GPs who
usually treat prostatic diseases. In order to address
potential sources of bias, cluster sample methodology
was retained. The participating clinicians were randomly
selected from the overall population of urologists and
GPs of every French region to rule out any geographic
parameter and to take into account the distribution of
the population in the country. The selected doctors had
to note in a register all LUTS/BPE patients over 40 years
old presenting two or more episodes of nocturia,
although they selected only a number of three patients
who had poor sleep, possibly secondary to BPE. We
believe that this design guaranteed the best representa-
tivity of the studied population.
This observational survey was approved by the
national authority for epidemiological database studies
(French National Commission for Data Protection and
the Liberties) and abided by French regulatory
requirements.
Data collection
During a patient’s visit, the investigator collected his age,
the duration of BPE since the diagnosis (<1, 1e5, 6e10
and >10 years),thenumberofepisodesofnocturiaduring
the previous night and the 24 h diuresis (millilitred
if known). BPE diagnosis was conﬁrmed by digital rectal
exam performed by the clinician.
< If patients with BPE did not complain of regular sleep
disorders, they were registered but were not included
in the survey.
< If they complained of regular sleep disorders,
insomnia and other sleep disorders, as well as
the characteristics of LUTS/BPE, were assessed
subjectively.
Instruments
Insomnia and other sleep disorders were assessed using
a self-administered questionnaire, the ‘Sleep Disorders
QuestionnairedFrench version’ (SDQFV). Excessive
sleepiness was assessed using the ‘Epworth Sleepiness
Scale’ (ESS).
The SDQFV is a 42-item questionnaire based on the
“Stanford Sleep Questionnaire and Assessment of
Wakefulness”.
20 The French version has been validated
in several epidemiological studies.
21 22 It covers sleep
habits, sleep disorders, alertness during the daytime and
psycho-behavioural items such as mood, memory and
sexual behaviour.
All but one of the items are derived from questions
and possible responses in the SDQFV. The selection of
sleep disorders was based on two reference documents:
the ‘International Classiﬁcation of Sleep Disorders
(ICSD-2)’
17 and the ‘Diagnostic and Statistical Manual of
Mental Disorders’, 4th revision (DSM-IV)
16 (table 1).
The SDQFV also collected data on four speciﬁc sleep
complaints: (1) difﬁculty falling asleep, (2) frequent
nocturnal awakenings, (3) early awakenings and (4)
non-restorative sleep.
A sleep log, a classic tool used in clinical practice and
sleep clinics to assess sleep on the previous night
(ﬁgure 1) was used to calculate sleep characteristics. It
also enquired whether the patient used a sleep drug
(occasionally, regularly or every day). The following
sleep parameters were calculated based on sleep logs:
total sleep period (TSP ¼ ﬁnal wake up time  
bedtime), sleep latency (SL ¼ period from lights off to
sleep), wake after sleep onset (WASO ¼ time of awak-
ening during the sleep period), number of awakenings
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  (WASO + SL)). Sleep efﬁciency index was deﬁned by
the ratio TST:TSP (SEI ¼ TST/TSP).
The ESS
23 was used to assess sleepiness. It is a well-
known subjective scale used in epidemiology and clinical
settings.
The subject scored his chances of dozing (0¼ would
never doze, 1¼ slight chance of dozing, 2¼ moderate
chance of dozing, 3¼ high chance of dozing) in eight
ordinary daily situations (watching TV, as a passenger in
a car for an hour without a break, sitting and talking
to someone, etc). Based on the total score, patients
can be classiﬁed in three subgroups of sleepiness: no
¼0e10, excessive sleepiness ¼10e16 or major sleepiness
>16.
Insomnia was deﬁned according to the DSM-IV and
ICSD-2 deﬁnitions
16 17:
< Subjects ﬁrst had to complain about difﬁculty
initiating sleep, nocturnal awakenings, early awaken-
ings or non-restorative sleep.
< Symptoms had to occur at least three nights per week
and for at least 1 month and
< Symptoms had to be accompanied by daytime
consequences: (1) fatigue or malaise; (2) attention,
concentration or memory impairment; (3) social or
vocational dysfunction or poor school performance;
(4) mood disturbance or irritability; (5) daytime
sleepiness; (6) motivation, energy or initiative reduc-
tion; (7) proneness to errors or accidents at work or
while driving; (8) tension, headaches or
Table 1 Deﬁnition of sleep disorders
Criteria for deﬁning sleep disorders were based on the DSM-IV and International Classiﬁcation of Sleep Disorders (ICSD) classiﬁcation criteria.
Items A to H were associated among these criteria to assess minimum criteria of the most common sleep disorders (ref
15 16). See for
methodology ref.
17 18
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Prostatic hyperplasia and excessive sleepinessgastrointestinal symptoms in response to sleep loss or
(9) concerns or worries about sleep.
– Severe insomnia was deﬁned as the presence of at
least two sleep complaints according to the DSM-IV
deﬁnition. In addition, the ICSD minimum criteria
for insomnia, idiopathic hypersomnia, snoring and sleep
apnoea were used. Information was also collected on
duration of sleep disorders.
Assessing characteristics of LUTS/BPE
The International Prostate Symptom Score
This seven-item self-reporting questionnaire is the
international reference tool used to assess the severity of
LUTS/BPE (global score S ¼0e35), with an additional
item scoring separately the QoL impact of LUTS
(6-grade scale from 0 to 5). Based on the obtained global
score S, the patients could be classiﬁed as presenting
mild (S ¼0e7), moderate (S ¼8e19) or severe
(S ¼20e35) LUTS.
24
The Nocturia-Speciﬁc Quality-of-Life Questionnaire
It assessing the impact of nocturia on patients’ QoL. It
includes sleep/energy and bother/concern subscales,
and one global QoL item. Among the 13 items, six are
related to sleep disturbances, measuring their conse-
quences on daily activities (lack of sleep, difﬁculty
concentrating, feeling low energy, needing to nap,
decreased productivity and participation in activities).
The different scores were determined by summing the
answers of each corresponding question, the sum being
then converted into a standardised scale from 0 to 100.
25
Statistical methods
Statistical analyses were performed using the SAS
software package (V.8.2, SAS Institute). Sleep parameters
and disorders (WASO, SEI, SL, TSP and TST, ESS scores
and the presence of insomnia, restless leg syndrome
(RLS) and OSA) were described for the entire sample
and according to the number of episodes of nocturia per
night (non-linear correlationdSpearman test), and the
severity of LUTS (International Prostate Symptom Score
(I-PSS)) and the volume of 24 h diuresis (> or
<1500 ml). According to the analysed variables and their
distribution, used statistical tests were Student t test,
paired t-test, McNemar test, CochraneManteleHaenszel
test, c
2 test, KruskaleWallis or Wilcoxon tests. All statis-
tical tests were two sided and signiﬁcant at a 0.05 a-risk
level and missing data were not replaced.
RESULTS
A total of 798 clinicians included 2299 patients. Because
some of the questionnaires were not fully completed, we
retained only 2179 of them. All the patients were males
aged on average 67.567.5 years.
Characteristics of LUTS/BPE are summarised in
table 2. Surveyed patients mostly had a moderate
(69.9%) or a severe (24.1%) LUTS based on the I-PSS;
66.6% had three or more episodes of nocturia per night
and 19% had more than four episodes. The 24 h diuresis
was recorded for 1019 patients: 38% had a volume
>1500 ml These LUTS deeply affect QoL based on I-PSS
QoL score L: 46.4% scored themselves as mostly dissat-
isﬁed because of their troubles and 10.8% as unhappy/
terrible. Sleep characteristics of patients with LUTS/BPE
are presented in table 3.
Impact of LUTS/BPE severity on sleep characteristics and
sleepiness
< As expected, the number of reported nocturia
episodes was associated with the number of awaken-
ings (ﬁgure 2). However, a higher number of nocturia
was also signiﬁcantly associated with a higher WASO
(from an average 70.5 min for one episode to
127.5 min for ﬁve or more episodes, p<0.001), TSP
(p<0.001), a decreased sleep efﬁciency (from an
average 79.0% for one episode to 69.2% for ﬁve or
more episodes, p<0.001) and an increased total sleep
period (from an average 8.6 h for one episode to
9.4 h for ﬁve or more episodes, p<0.001). Conversely,
the sleep latency was not affected by the number of
nocturia episodes and the TST also do not vary.
< Reporting a 24 h diuresis (#1500 or >1500 ml) was
not associated with any of the sleep characteristics
items: number of awakenings per night (2.860.8 vs
2.960.9, p¼0.260), sleep latency (30.2636.9 vs
Figure 1 Sleep diary/log.
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88644 min, p¼0.745), TST (6.761.4 vs 6.861.3 h,
p¼0.142), TSP (8.961.1 vs 8.961.1 h, p¼0.751) or
SEI (74.9614.0 vs 76.6611.8%, p¼0.174).
< However, the I-PSS classes had a signiﬁcant effect on
SEI (74.2612.1% for severe, 76.3612.7% for
moderate and 80.7610.6% for mild, p<0.001)
(table 4), WASO, TST and the number of awakenings
per night (p<0.001 for each value) but none on sleep
latency and TSP.
Impact of LUTS/BPE severity on insomnia and other sleep
disorders
Among the 2179 patients with poor sleep who completed
the HD-43 sleep questionnaire, 60.9% responded to the
deﬁnition of insomnia according to the international
classiﬁcations. Beside these insomniacs, an additional
7.9% responded to the subjective criteria for RLS and
6.4% to the minimum subjective criteria in favour of sleep
apnoea (OSA). Sleepiness was high (ESS >10) in 32.3%
of the patients and major in 3.1% of them ESS (>16).
< The number of reported nocturia episodes was
signiﬁcantly associated with the presence of insomnia:
95% of patients with ﬁve or more episodes of nocturia
had insomnia versus 36.9% of those with two episodes
(p<0.001). Conversely, insomniacs reported more
nocturia episodes (3.160.9 (95% CI 3.0 to 3.1))
than non-insomniacs (2.660.9 (95% CI 2.5 to 2.7),
p<0.001). Patients with LUTS/BPE complained more
often of nocturnal awakenings than difﬁculty initi-
ating sleep (48.9% vs 21.4%, p<0.001, 42.5% had
both). Overall, 78.6% of subjects reported normal
sleep latency <30 min, 16.2% between 30 and 60 min
and only 5.2% above 60 min.
< Reporting a 24 h diuresis (#1500 or >1500 ml) did
not affect the frequency of insomnia (55.6% vs
62.7%) (NS).
< The I-PSS was higher in insomniacs than in subjects
with no insomnia (17.5 (65.4) vs 15.6 (65.5),
p<0.001), and insomnia was more prevalent in
subjects with a severe I-PSS than in those with
moderate or mild scores (p<0.001).
The number of nocturia episodes was signiﬁcantly
associated with more reported sleepiness and excessive
sleepiness (ESS >16). The 24 h diuresis volume also
Table 3 Sleep characteristics of patients with lower
urinary tract symptoms/benign prostatic hyperplasia
Number of awakenings* (n¼2029) 2.860.9
Mean 6 SD (min; median; max) 0; 3; 10
Sleep latency (n¼2029) 27.2631.3 min
Mean 6 SD (min; median; max) 0; 30; 330
#30 min, % patients (n) 78.6 (1517)
>30e#60 min, % patients (n) 16.2 (313)
>60 min, % patients (n) 5.2 (100)
Wake after sleep onset (n¼2010) 89.2647.5 min
Mean 6 SD (min; median; max) 0.; 90; 390
#30 min, % patients (n) 10.1 (203)
>30e#60 min, % patients (n) 28.6 (575)
>60 min, % patients (n) 61.3 (1232)
Total sleep period* (n¼2047) 8.961.1 h
Mean 6 SD (min; median; max) 5.1.; 9.0; 13.0
Total sleep time* (n¼2007) 6.761.4 h
Mean 6 SD (min; median; max) 0.3.; 6.8; 12.0
Sleep efﬁciency index* (n¼2029) 76.0612.8%
Mean 6 SD (min; median; max) 9.; 78; 100
ESS (n¼2059) 8.164.3
Mean 6 SD (min; median; max) 0.; 8; 24
No sleepiness ESS #10, %
patients (n)
64.6 (203)
Excessive sleepiness ESS
11e15, % patients (n)
32.3 (575)
Major sleepiness ESS $16,
% patients (n)
3.1 (1232)
*Previous night.
Epworth Sleepiness Scale.
Table 2 Characteristics of LUTS/BPE
BPE, benign prostatic hyperplasia; I-PSS, International Symptom Score Prostate; LUTS, lower urinary tract symptoms; N-QoL, Nocturia-
Speciﬁc Quality-of-Life Questionnaire.
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ation found between the I-PSS and ESS.
There was no signiﬁcant association between RLS and
sleep apnoea minimum criteria and any BPE symptom.
DISCUSSION
One major ﬁnding of this study is that older men
complaining of LUTS related to BPE have poor sleep as
reported by many studies
4e8 and a high prevalence of
insomnia, as assessed by well-validated tools. In a group
of 2179 patients with LUTS and nocturia, visiting GPs
and urologists, carefully representative of the clinicians
who usually take care of BPE in France, found a high
prevalence of insomnia (60.9%): more than three times
greater than that observed (with the same tools) in the
general population of France (ie, 19% in 12778
subjects).
21 Although these studies cannot be compared
from a statistical point of view, we can suggest that
insomnia is a major underestimated complaint in this
group of LUTS patients. Ageing has a normal effect on
sleep quality and quantity
26 27: sleep in older people is
commonly shorter than in younger adults, with a lower
percentage of slow wave sleep.
27 It is also common that,
due to a phase advance of the biological clock, older
people get to sleep earlier in the evening, with an earlier
awakening in the morning. Insomnia is also more prev-
alent in older subjects and is estimated to affect 30%e
40% of them, mostly women.
11 13e15 18 19 26 Facing this
high prevalence of sleep disturbance, GPs and urologists
may be tempted to consider poor sleep as an unavoid-
able consequence of ageing. Our study demonstrated
that this is not only a question of ageing but it is also
associated with the severity of nocturia. Based on these
results, we ﬁrmly encourage GPs to investigate more
deeply a possible link between the two disorders and to
use well admitted sleep and LUTS/BPE instruments to
assess the severity of illness.
This is the second issue highlighted by our study,
which shows that some tools used to describe HGB may
be signiﬁcantly associated with the severity of insomnia:
< First, the I-PSS, which has been recommended to
assess the impact of LUTS/BPE on QoL, was
signiﬁcantly associated with insomnia in our study.
The I-PSS in insomniacs was higher than in subjects
with no insomnia, and insomnia was more prevalent
in subjects with a severe I-PSS than in those with-
moderate or mild scores. The severity of I-PSS
also signiﬁcantly correlates with SEI and excessive
somnolence as measured by the ESS.
< Second, the number of nocturia episodes had
a signiﬁcant impact on the severity of insomnia. It
may seem obvious that the more times one needs to
void the bladder at night, the more awakenings result.
Our study describes which sleep parameters were
affected by the frequency of nocturia. As shown, it did
not affect total sleep time, which means that patients
with severe BPE did not sleep less than others in our
survey. However, they had longer WASO and they
compensated by staying in bed more with a longer
total sleep period. Staying in bed is not recom-
mended for insomniacs since it decreases sleep
homeostatic power and may increase insomnia. It is
possible that in these elderly subjects, staying in bed
too much at night may decrease the quality of their
sleep, driving them to be more sensitive to prostatic
pressure, which may prompt them to go to the
bathroom more often.
Interestingly, our study also allows us to better under-
stand how sleep is disturbed and leads to insomnia in
Figure 2 Impact of lower urinary tract symptoms/benign
prostatic hyperplasia on sleep characteristics and sleepiness.
SEI, sleep efﬁciency index; SL, sleep latency; TST, total sleep
time; WASO, wake after sleep onset.
Table 4 Characteristics of LUTS/BPE and sleep efﬁciency
BPE, benign prostatic hyperplasia; I-PSS, International Symptom Score Prostate; LUTS, lower urinary tract symptoms; SEI, sleep efﬁciency
index.
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28 29 it
was assessed that nocturia was strongly associated with
insomnia. However, insomnia was just deﬁned by
a complaint of poor sleep with or without daytime
consequences.
In more recent consensus or review papers, the impact
of nocturia on sleep was mainly focused on QoL scales.
However, it has been shown that insomnia has a signiﬁ-
cant impact on QoL,
30e32 it seems difﬁcult to think that
the disturbed QoL in LUTS/BPE patients with poor
sleep may be only associated with the disturbed sleep
and not with other possible factors due to BPE such as
pain, anxiety or depression.
In our study, we obtained additional interesting data to
better understand insomnia in these patients.
< First, difﬁculty initiating sleep affected 21.4% of them
versus 48.9% affected by nocturnal awakenings,
42.5% had both. This has not been previously
described in other papers as difﬁculty initiating
sleep does not ﬁt with nocturia. We may hypothesise
that nocturia may disturb sleep events at the
beginning of the night with patients going to the
toilet just after going to sleep to avoid future
awakenings at night. Difﬁculty initiating sleep may
also be associated with many other causes such
anxiety, environment or pain.
< Second, the patients in our group were not severely
sleep deprived. Some authors have suggested that
LUTS/BPE subjects may be severely sleep deprived
and have associated risks due to sleepiness or
fatigue.
24 28
Our study shows that the number of nocturia episodes
did not affect total sleep time (ﬁgure 2); patients with
frequent awakenings related to nocturia episodes spent
more time in bed (TSP) to reach comparable effective
sleep duration TST, with a signiﬁcant increased WASO
and decreased SEI. By being disruptive to sleep, the
nocturia episodes affected sleep efﬁciency and quality,
with no reduction of the quantity of sleep, which is
within the limits of normal for this age group.
27 Simi-
larly, the urine volume per day has no impact on TST.
We, however, showed that the number of nocturia
episodes was associated with an increased sleepiness
assessed by the ESS. The ESS score was above 10 for
24.5% of men with two nocturia versus 36.8% of those
with more than ﬁve episodes (and an ESS score above 16
for 0.5 vs 4.8% p<0.001). Considering that total sleep
time is not reduced in those patients, we may hypothe-
sise that the quality of sleep is insufﬁcient, which
may explain excessive sleepiness during the day. The
urge to void the bladder probably acts like other sleep
disorders (sleep apnoea or RLS), resulting in sleep
fragmentation and increased sleepiness the day after. We
are aware that to conﬁrm this hypothesis, poly-
somnography studies are needed as it is not possible to
ascertain that the sleep quality of these patients is
disturbed using subjective tools only. Moreover, we have
made only one sleep assessment on the night before
clinician’s visit. However, questionnaires are well
accepted in the ﬁeld as they have shown their consis-
tency over time and across countries.
We also recognised several other limitations in this
study. First, our study is a cross-sectional and observa-
tional study made in a group of patients who have sleep
complaints and LUTS/BPE. It would have been more
convincing to compare them to a similar group of older
people with no LUTS/BPE. However, our study focused
on the frequency of insomnia and on the correlates
between LUTS/BPE and insomnia. The design of our
study allowed us to answer more precisely to this second
point.
It has been suggested that the frequency of nocturnal
voids and the time the episodes occur may affect sleep
quality. Deep, slow wave restorative sleep occurs during
the ﬁrst hours of the night, while in the second part, the
lighter and less restorative sleep predominates. Such
a decrease in deep sleep mainly contributes to daytime
fatigue. Based on this, the concept of hours of undis-
turbed sleep was developed and broadly acknowledged
as a potentially important parameter in assessing sleep
disturbance due to nocturnal voids.
4 24 33 Hours of
undisturbed sleep was deﬁned as the time from falling
asleep to ﬁrst wakening to void, the limit considered as
normal being 3e4 h. During this survey, the occurrence
time of the ﬁrst nocturnal void was not determined
according to the time the patients fell asleep. Never-
theless, as assessed by the I-PSS item-2, 47.9% of the
patients with chronic insomnia experienced the need to
void <2 h after a miction in at least 1 of 2 cases
compared with 28.9% and 26.7% of the patients,
respectively, with or without sleep disorders (p<0.001).
This could signify that patients with more severe sleep
disorders were more likely to need to wake up to void
during the ﬁrst part of the night.
The results obtained in this French multicenter
observational survey, conducted in routine practice in
2197 men with LUTS/BPE with associated sleep disor-
ders for 1576 patients, showed that the most prevalent
sleep disorder was chronic insomnia, mainly charac-
terised by sleep disruption. The number of nocturia
episodes appears to be the major driver of insomnia and
subsequent decrease in daytime alertness.
1 33 34 Thus, in
patients consulting mainly their GP for LUTS, it is
recommended to look for possible related sleep disor-
ders and inversely. Tools such as the simpliﬁed
SQHDdHD-43 that allows to determine the accurate
type of sleep disorders and other possibly associated
primary sleep disorders, as well as a patient’s sleep log, I-
PSS, ESS self-administered questionnaires that provide
sensitive and reliable quantitative measurements for
assessing the sleep disorders and their impact on the
QoLdare easy to use in routine practice.
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